
Biocon Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Press Release titled Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara?, in Europe, UK, Canada, and Japan ".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Press Release titled Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara?, in Europe, UK, Canada, and Japan ".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon